Homepage > Nachrichten > Text

Insight into the Chinese Orthopedic Surgical Power System Market in 2024

2025-07-04

The main domestic manufacturers of orthopedic surgical power systems include Stryker, Zirui Power, Xishan Technology, Bojin, Xiyi, etc.

This report aims to conduct a comprehensive analysis of the scale, brand landscape, and regional differential performance of the domestic orthopedic surgical power system market in 2024, and gain insights into the market trends.

1. The market size  witnessed robust growth, with national brands contributing over 60%.

In 2024, the market size of the domestic orthopedic surgical power system showed a strong year-on-year growth momentum, with a year-on-year growth rate exceeding 37%.

In 2024, the market share of domestic brands in the domestic orthopedic surgical power system market exceeded 60%, an increase of approximately 6 percentage points compared to the same period last year.

02 The market competition pattern changed, and market concentration further increased.

In 2024, in the domestic orthopedic surgical power system market, the market concentration of the top four brands (CR4) reached 72.78%, an increase of approximately 7 percentage points compared to the same period last year, and market competition further intensified.

03   In the eastern region, procurement expanded, while in the central and western regions, there was a greater preference for purchasing national brands.

In 2024, the procurement proportion of orthopedic surgical power systems in the eastern region of China increased significantly, by approximately 8 percentage points.

In terms of brand market share, the proportion of purchasing national brands in the western and central regions is around 70%, and the proportion in the eastern and northeastern regions is around 53%.

04  The proportion of products sold to tertiary hospitals  further increased, and secondary hospitals were more inclined to purchase national brands.  

In 2024, in the domestic orthopedic surgical power system market, the purchasing units were still mainly tertiary hospitals, with the proportion increasing by 3 percentage points.

In terms of brand market share, the proportion of secondary hospitals purchasing domestic brands was higher, approximately 82%, while the proportion of tertiary hospitals purchasing domestic brands is 52%.

05 Conclusion 

With the influence of factors such as population aging, the number of orthopedic surgeries in China has increased, driving a significant growth in the market size of orthopedic surgical power systems. The year – on – year growth rate in 2024 exceeded 30%. In April 2024, the National Health Commission issued the “Configuration Standards for Medical Equipment in Operating Rooms” (WS/T 835 – 2024), listing surgical power systems (and accessories) as equipment that tertiary hospitals should be equipped with, that is, the minimum number of configurations for tertiary hospitals is 1 unit. It came into effect in November of the same year, continuously injecting new impetus into the expansion of the surgical power system market in China.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source:JOINCHAIN
Translated & edited:Bradyknown